glucose, (beta-d)-isomer has been researched along with 18f-faza in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beck, R; Haubner, R; Johnson, TD; Machulla, HJ; Picchio, M; Piert, M; Reischl, G; Schwaiger, M; Seidl, S; Wester, HJ | 1 |
Eschmann, SM; Langen, KJ | 1 |
Boerman, OC; Bussink, J; Kaanders, JH; Laverman, P; Oyen, WJ; Troost, EG | 1 |
Cheeseman, C; Khlebnikov, V; Kumar, P; Liang, H; Shustov, G; Wiebe, LI; Yang, XH; Zheng, W | 1 |
4 other study(ies) available for glucose, (beta-d)-isomer and 18f-faza
Article | Year |
---|---|
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography.
Topics: Animals; Autoradiography; Cell Hypoxia; Female; Fluorine Radioisotopes; Glucosides; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iodine Radioisotopes; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Nitroimidazoles; Oligopeptides; Radionuclide Imaging | 2008 |
Correlative imaging of hypoxia and angiogenesis in oncology.
Topics: Autoradiography; Cell Hypoxia; Glucosides; Humans; Neoplasms; Neovascularization, Pathologic; Nitroimidazoles; Oligopeptides; Positron-Emission Tomography | 2008 |
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-gluco-RGD autoradiography.
Topics: Animals; Diagnostic Imaging; Glucosides; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Iodine Radioisotopes; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Nitroimidazoles; Oligopeptides; Radiopharmaceuticals; Research Design | 2008 |
Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors.
Topics: Cell Hypoxia; Cell Line, Tumor; Drug Design; Glucose Transport Proteins, Facilitative; Glucosides; Glycosides; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radionuclide Imaging; Radiopharmaceuticals; Transcriptional Activation | 2012 |